TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: HDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Episodes of febrile neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Median number of days with absolute neutrophil count < 500/microl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Median number of days with platelet count < 25,000/microl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction with anesthesia method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average hair regrowth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incisor protrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distal tipping of molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach platelet counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to reach neutrophil counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of platelet transfusions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proactive memory interference effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription rate of antibiotics against URTIs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean skin temperature at vasoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean skin temperature at shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing time after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: KPS score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: B lymphocyte improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prenatal diagnosis of placenta accreta/percreta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Diagnosis of vasa previa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Arrhythmia-free survival without antiarrhythmic drug therapy
Endpoint domain: Mortality/survival
Primary endpoint: Multiple procedure success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: treatment outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI 75 response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost per responder
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cTnI levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative wound pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful external cephalic version
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to discharge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of infections
Endpoint domain: Adverse events/effects
Primary endpoint: absence due to MSDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric pHi values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: surgical costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fusobacterium spp. abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiorespiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: body-mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-RM bench press performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle pennation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fascicle lengths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: protein intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrepancy shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrepancy occlusal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total utilized meperidine dose
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Fat mass percentage (FM%) SD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lean body mass (LBM) SD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood pressure SD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: General diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum hepcidin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicity composite end point
Endpoint domain: Adverse events/effects
Primary endpoint: PMH/SMS involving at least two areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PMH/SMS involving three areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day CT compatible with lacunar infarct
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PDPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hb level maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: social/family well-being
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Myocardial blush grade 2/3 as a predictor of lower mortality
Endpoint domain: Mortality/survival
Primary endpoint: STR ≥50% as a predictor of freedom from repeated revascularization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of leaking samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visualization of internal mammary sentinel lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of small myelinated nerve fibres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in number of large myelinated nerve fibres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time required to reach study discharge criteria (asthma score < or = 2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of improvement of the clinical asthma score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepcidin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ferritin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Agreement rates between medication lists and patient report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of AO (Aphthous Ulcers)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MTX-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Withdrawal due to MTX-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Liver toxicity (increased serum liver enzymes)
Endpoint domain: Adverse events/effects
Primary endpoint: Failure rates of resin-bonded and conventional FPDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfactory rates of clinical results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of secondary caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BPH symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum urinary flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean prostate volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: job stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: job satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NICE compliance
Endpoint domain: Resource use
Primary endpoint: >50% stenosis on CCTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Residual ST deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Infarct size (CK levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of diaphragmatic fatigue disappearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in nasolabial angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in interincisal angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in facial height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final exam scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical outcome measures (PAL gain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcome measures (PPD reduction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcome measures (RAD gain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerance of idebenone
Endpoint domain: Adverse events/effects
Primary endpoint: plasma levels of total idebenone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in overall endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in muscular strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average skills score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative spectral power in the δ band
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spectral edge frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean dominant frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Achieving BCVA of 0.5 or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving target IOP without anti-glaucoma medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women with antenatal psychosocial risk factors for PPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of risk factors per woman
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of depressive symptomatology during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-heal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with A1C <7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting plasma glucose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Zinc concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: knowledge and prevalence estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coping effort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: amount of information received about the disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: helpfulness of the information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: understanding of their illness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: improvements to anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvements to depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ankle pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: colonic MPO activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: colonic concentration of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median changes in the mSASSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: time to relapse
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: median total time asleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Rate of Surgical Site Infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative ileus incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Non-Surgical Site Complications (NSSC) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of the post-operative period
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: implant success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to perform Activities of Daily Living (ADL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical unsteadiness of gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelium-dependent vasomotor capacity of coronary arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Flow-dependent vasodilation (FDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total peripheral resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ACL-QOL improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IKDC grade improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee laxity measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SA levels in preterm labor group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent cTnI elevation >0.01 microg/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 8-iso-PGF(2alpha) levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diameters of the coronary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vasoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IL 6 and IL 10 release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rehospitalization rates
Endpoint domain: Mortality/survival
Primary endpoint: employment rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: patient's functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Changes in fasting insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in HOMA‐IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: eye movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: active movements per tactile input
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall behavioral reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STS ability improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of FS and TE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAF episodes per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PAF burden (min/d)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Enlarged RLN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: accuracy of auditory status identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRC screening preference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readiness to receive screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CRC screening tests ordered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to chemotherapeutic regimen
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Median survival at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Number of side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Forced expiratory volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Preference for future management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean hemoglobin levels at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of IUTs performed after randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Satisfaction with intrapartum care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 7-day point-prevalence self-reported tobacco abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDAI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cholesterol/HDL ratio change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CAARS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GWB subscale scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sheehan Disability Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: composite endpoint of death, lung transplantation, hospitalization, or FVC decline
Endpoint domain: Mortality/survival
Primary endpoint: Visual Analog Scale (VAS) score after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade 4 leucopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Voriconazole concentration in vitreous humour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Replacement rate due to recurrent caries in primary teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repair rate of restorations in permanent teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of seizures decreased by greater than 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients free of seizures at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: hub colonization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of grade 3 or greater treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: FMA-UL score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: children's preoperative anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes